Brief: ORIC Pharmaceuticals Q2 Net Income USD -31.963 Million
12/08/2024 21:05
Aug 12 (Reuters) - ORIC Pharmaceuticals Q2 basic EPS USD -0.45 vs. IBES estimate USD -0.41. * Q2 income from operations USD -36.017 million * Q2 operating expenses USD 36.017 million
Recent news on ORIC Pharmaceuticals
See all newsBrief: Oric® Pharmaceuticals Announces Agreement With Cancer Research UK
ORIC Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: ORIC Pharmaceuticals Q1 Operating Expenses USD 39.619 Million
Brief: Oric Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ORIC Pharmaceuticals Q4 loss narrows